Clinical trial

Switch to Maraviroc + Integrase Inhibitor

NCT01896921

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2013-09-01

PhasePHASE3

Study timeline

Study start (actual)2013-09-01Date precision: month

Registry last updated2021-10-20

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

HIVunresolved

Interventions

Switch to Maraviroc + Raltegravir or DolutegravirDRUG

Sponsors & collaborators

University of Maryland, Baltimorelead sponsor

Mapped research locations

BaltimoreMaryland, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01896921 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.